vs
FIRST UNITED CORP（FUNC）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
FIRST UNITED CORP的季度营收约是STANDARD BIOTOOLS INC.的1.2倍（$23.2M vs $19.6M），FIRST UNITED CORP净利率更高（24.9% vs -177.4%，领先202.3%），FIRST UNITED CORP同比增速更快（11.9% vs -11.5%），FIRST UNITED CORP自由现金流更多（$15.4M vs $-23.1M），过去两年FIRST UNITED CORP的营收复合增速更高（11.5% vs -12.2%）
联合啤酒控股有限公司（又称UB集团）是喜力集团旗下的印度子公司，总部位于卡纳塔克邦班加罗尔的UB城。公司核心业务涵盖酒类饮品生产及多领域投资，是印度最大的啤酒生产商，主打以翠鸟为品牌的啤酒产品，同时拥有多款其他酒类品牌。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
FUNC vs LAB — 直观对比
营收规模更大
FUNC
是对方的1.2倍
$19.6M
营收增速更快
FUNC
高出23.3%
-11.5%
净利率更高
FUNC
高出202.3%
-177.4%
自由现金流更多
FUNC
多$38.5M
$-23.1M
两年增速更快
FUNC
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $23.2M | $19.6M |
| 净利润 | $5.8M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 32.9% | -168.5% |
| 净利率 | 24.9% | -177.4% |
| 营收同比 | 11.9% | -11.5% |
| 净利润同比 | -6.6% | -28.8% |
| 每股收益（稀释后） | $0.89 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FUNCLAB
| Q4 25 | $23.2M | — | ||
| Q3 25 | $22.7M | $19.6M | ||
| Q2 25 | $21.8M | $21.8M | ||
| Q1 25 | $20.9M | $40.8M | ||
| Q4 24 | $20.8M | — | ||
| Q3 24 | $20.3M | $22.1M | ||
| Q2 24 | $20.1M | $22.5M | ||
| Q1 24 | $18.7M | $45.5M |
净利润FUNCLAB
| Q4 25 | $5.8M | — | ||
| Q3 25 | $6.9M | $-34.7M | ||
| Q2 25 | $6.0M | $-33.5M | ||
| Q1 25 | $5.8M | $-26.0M | ||
| Q4 24 | $6.2M | — | ||
| Q3 24 | $5.8M | $-26.9M | ||
| Q2 24 | $4.9M | $-45.7M | ||
| Q1 24 | $3.7M | $-32.2M |
毛利率FUNCLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率FUNCLAB
| Q4 25 | 32.9% | — | ||
| Q3 25 | 40.6% | -168.5% | ||
| Q2 25 | 36.5% | -118.1% | ||
| Q1 25 | 36.8% | -80.8% | ||
| Q4 24 | 39.2% | — | ||
| Q3 24 | 38.0% | -120.9% | ||
| Q2 24 | 32.5% | -134.5% | ||
| Q1 24 | 26.0% | -132.2% |
净利率FUNCLAB
| Q4 25 | 24.9% | — | ||
| Q3 25 | 30.6% | -177.4% | ||
| Q2 25 | 27.5% | -153.7% | ||
| Q1 25 | 27.7% | -63.8% | ||
| Q4 24 | 29.8% | — | ||
| Q3 24 | 28.5% | -122.0% | ||
| Q2 24 | 24.5% | -203.3% | ||
| Q1 24 | 19.8% | -70.6% |
每股收益（稀释后）FUNCLAB
| Q4 25 | $0.89 | — | ||
| Q3 25 | $1.07 | $-0.09 | ||
| Q2 25 | $0.92 | $-0.09 | ||
| Q1 25 | $0.89 | $-0.07 | ||
| Q4 24 | $0.95 | — | ||
| Q3 24 | $0.89 | $-0.07 | ||
| Q2 24 | $0.75 | $-0.12 | ||
| Q1 24 | $0.56 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $131.6M | $129.4M |
| 总债务越低越好 | $95.9M | — |
| 股东权益账面价值 | $203.6M | $399.7M |
| 总资产 | $2.1B | $539.6M |
| 负债/权益比越低杠杆越低 | 0.47× | — |
8季度趋势，按日历期对齐
现金及短期投资FUNCLAB
| Q4 25 | $131.6M | — | ||
| Q3 25 | $95.2M | $129.4M | ||
| Q2 25 | $79.1M | $158.6M | ||
| Q1 25 | $84.4M | $150.9M | ||
| Q4 24 | $78.3M | — | ||
| Q3 24 | $62.4M | $210.6M | ||
| Q2 24 | $45.1M | $269.8M | ||
| Q1 24 | $86.9M | $287.1M |
总债务FUNCLAB
| Q4 25 | $95.9M | — | ||
| Q3 25 | $95.9M | — | ||
| Q2 25 | $120.9M | — | ||
| Q1 25 | $120.9M | — | ||
| Q4 24 | $120.9M | — | ||
| Q3 24 | $120.9M | $55.2M | ||
| Q2 24 | $70.9M | $55.1M | ||
| Q1 24 | $70.9M | $55.0M |
股东权益FUNCLAB
| Q4 25 | $203.6M | — | ||
| Q3 25 | $199.1M | $399.7M | ||
| Q2 25 | $191.1M | $424.5M | ||
| Q1 25 | $183.7M | $454.6M | ||
| Q4 24 | $179.3M | — | ||
| Q3 24 | $174.0M | $489.3M | ||
| Q2 24 | $164.2M | $510.3M | ||
| Q1 24 | $165.5M | $577.3M |
总资产FUNCLAB
| Q4 25 | $2.1B | — | ||
| Q3 25 | $2.0B | $539.6M | ||
| Q2 25 | $2.0B | $557.0M | ||
| Q1 25 | $2.0B | $579.6M | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | $681.5M | ||
| Q2 24 | $1.9B | $708.7M | ||
| Q1 24 | $1.9B | $777.7M |
负债/权益比FUNCLAB
| Q4 25 | 0.47× | — | ||
| Q3 25 | 0.48× | — | ||
| Q2 25 | 0.63× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.67× | — | ||
| Q3 24 | 0.70× | 0.11× | ||
| Q2 24 | 0.43× | 0.11× | ||
| Q1 24 | 0.43× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.4M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $15.4M | $-23.1M |
| 自由现金流率自由现金流/营收 | 66.3% | -118.1% |
| 资本支出强度资本支出/营收 | 17.1% | 4.5% |
| 现金转化率经营现金流/净利润 | 3.35× | — |
| 过去12个月自由现金流最近4个季度 | $22.7M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流FUNCLAB
| Q4 25 | $19.4M | — | ||
| Q3 25 | $1.5M | $-22.2M | ||
| Q2 25 | $995.0K | $-20.7M | ||
| Q1 25 | $7.0M | $-30.3M | ||
| Q4 24 | $22.3M | — | ||
| Q3 24 | $2.3M | $-27.9M | ||
| Q2 24 | $7.2M | $-39.0M | ||
| Q1 24 | $3.6M | $-62.5M |
自由现金流FUNCLAB
| Q4 25 | $15.4M | — | ||
| Q3 25 | $168.0K | $-23.1M | ||
| Q2 25 | $706.0K | $-22.6M | ||
| Q1 25 | $6.4M | $-35.3M | ||
| Q4 24 | $20.4M | — | ||
| Q3 24 | $588.0K | $-30.1M | ||
| Q2 24 | $7.0M | $-41.0M | ||
| Q1 24 | $3.5M | $-63.3M |
自由现金流率FUNCLAB
| Q4 25 | 66.3% | — | ||
| Q3 25 | 0.7% | -118.1% | ||
| Q2 25 | 3.2% | -103.6% | ||
| Q1 25 | 30.5% | -86.6% | ||
| Q4 24 | 98.1% | — | ||
| Q3 24 | 2.9% | -136.4% | ||
| Q2 24 | 35.1% | -182.2% | ||
| Q1 24 | 18.9% | -138.9% |
资本支出强度FUNCLAB
| Q4 25 | 17.1% | — | ||
| Q3 25 | 5.9% | 4.5% | ||
| Q2 25 | 1.3% | 8.7% | ||
| Q1 25 | 2.8% | 12.4% | ||
| Q4 24 | 9.3% | — | ||
| Q3 24 | 8.4% | 10.2% | ||
| Q2 24 | 0.6% | 8.6% | ||
| Q1 24 | 0.3% | 1.7% |
现金转化率FUNCLAB
| Q4 25 | 3.35× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 1.20× | — | ||
| Q4 24 | 3.60× | — | ||
| Q3 24 | 0.40× | — | ||
| Q2 24 | 1.46× | — | ||
| Q1 24 | 0.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FUNC
| Trust Department | $9.8M | 42% |
| Other | $5.6M | 24% |
| Debit Card Income | $4.1M | 17% |
| Service Charges | $2.3M | 10% |
| Brokerage Commissions | $1.4M | 6% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
